Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now early-phase tilt small index

Insulinoma: early-phase trial registry

2 of 6 indexed Insulinoma trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #2,866 of 28,707 conditions by registered trial count.

Jump to open trials → Trial finder

6 US clinical trials · 2 currently recruiting · #2,866 of 28,707 conditions by registered trial count

Insulinoma: 6 US clinical trials tracked, 2 recruiting.

Insulinoma is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), running 2 of these trials.

Enrollment posture brief

Registry condition insulinoma

OPEN 2 | RECR 33% | LATE 0 | EARLY 4 | RANK #2866 | SPON 2

Volume-matched condition peers

Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)

Acute Hypoxemic Respiratory 66.7%Abdominal Aortic Aneurysms50%Acupuncture50%Acute Lymphoblastic Leukemia50%Insulinoma (this)33%
Open-enrollment share among volume-matched conditions near Insulinoma

Insulinoma lists 2 open slots (33% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Insulinoma on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Insulinoma is recruiting below its size-band peers.

    2 of 6 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Insulinoma research.

    National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) accounts for 2 of 6 trials (33.3%). 5 distinct sponsors appear on at least one study for this condition label.

  3. Typical Insulinoma enrolment sits around 144 participants.

    Median target enrolment is 144 among the 6 trials that report a genuine target (sentinel values excluded). 3 of those (50%) plan for fewer than 100 participants.

  4. Insulinoma research is mostly interventional.

    5 interventional and 1 observational studies make up this index (83.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 12Phase 22

Phase Distribution

PhaseTrial count
Phase 1 2
Phase 2 2

Top Sponsors

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 2 trials
ECOG-ACRIN Cancer Research Group 1 trials
Cook Children's Health Care System 1 trials
Mayo Clinic 1 trials
National Cancer Institute (NCI) 1 trials

Named interventions

Most-linked intervention names on Insulinoma records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Intraoperative ultrasound Procedure
1 trials
vatalanib Drug
1 trials
sorafenib tosylate Drug
1 trials
dynamic contrast-enhanced magnetic resonance imaging Procedure
1 trials
everolimus Drug
1 trials
pharmacological study Other
1 trials
capecitabine Drug
1 trials
temozolomide Drug
1 trials

US sites by state

Facility locations filed on Insulinoma trials. A trial with sites in several states counts in each.

Minnesota 2 trials
Maryland 2 trials
Texas 1 trials
California 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Insulinoma page

6 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Insulinoma condition card totals 6 registered trials; most-linked intervention Intraoperative ultrasound; top US site state Minnesota. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.